Academy of Sciences of the Czech republic › About AS CR › AS CR Structure › Research institutes › ziva
Institute of Organic Chemistry and Biochemistry of the ASCR, v. v. i.
Institute of Organic Chemistry and Biochemistry of the ASCR, v. v. i.
Flemingovo nám. 2
166 10 Praha 6
166 10 Praha 6
Phone: +420 220 183 111
FAX: +420 220 183 578
E-mail: uochb@uochb.cas.cz
Chart: uochb_chart.pdf
The Institute is the successor of the Central Institute of Chemistry founded in 1950, which was incorporated into the Czechoslovak Academy of Sciences in 1953. After the division of the Academy’s Institute of Chemistry, the larger part became known as the Academy’s Institute of Organic Chemistry and Biochemistry.
The Institute traditionally combines organic chemistry with the fields of biology and medicine.
The main fields of research are:
The Institute traditionally combines organic chemistry with the fields of biology and medicine.
The main fields of research are:
- Medicinal chemistry, directed at chemotherapy for life-threatening and malignant diseases (antimetabolites, hormone analogues, antiviral and anticancer drugs).
- Chemical relationships between living objects in nature, concentrated on environmentally non-detrimental and necessary human interventions in nature (pheromones, insect antifeedants).
- Synthetic approaches aimed at developing new organic functional materials with compartments of nanometer size (conducting and half-conducting materials, supramolecular self-assemblies).
- These central themes are extended to include theoretical research on the chemical principles of the interrelation in living cells (enzyme catalysis, isolation and investigation of key enzymes in cell metabolism and their natural /protein/ or synthetic inhibitors), physico-chemical methods of studying these relationships and their theoretical modelling.
Her parents are employed in the IMG (project BIOCEV). Because Katareeya originates from a “third country”, namely, Australia, according to the Czech legislation she is not entitled to healthcare support from the public healthcare insurance.
The cost of intensive therapy during first two months have already exceeded the limits of private insurance in the amount of 1,6 million CZK. All the cost now repose only on the girl’s parents.
More information...